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Abstract
Background
Tsetse flies are the main vectors of human and animal African trypanosomes. The Tsal pro-
teins in tsetse fly saliva were previously identified as suitable biomarkers of bite exposure. A
new competitive assay was conceived based on nanobody (Nb) technology to ameliorate
the detection of anti-Tsal antibodies in mammalian hosts.
Methodology/Principal Findings
A camelid-derived Nb library was generated against the Glossina morsitans morsitans sia-
lome and exploited to select Tsal specific Nbs. One of the three identified Nb families (family
III, TsalNb-05 and TsalNb-11) was found suitable for anti-Tsal antibody detection in a com-
petitive ELISA format. The competitive ELISA was able to detect exposure to a broad range
of tsetse species (G. morsitans morsitans,G. pallidipes,G. palpalis gambiensis andG. fus-
cipes) and did not cross-react with the other hematophagous insects (Stomoxys calcitrans
and Tabanus yao). Using a collection of plasmas from tsetse-exposed pigs, the new test
characteristics were compared with those of the previously describedG. m. moristans and
rTsal1 indirect ELISAs, revealing equally good specificities (> 95%) and positive predictive
values (> 98%) but higher negative predictive values and hence increased sensitivity (> 95%)
and accuracy (> 95%).
Conclusion/Significance
We have developed a highly accurate Nb-based competitive immunoassay to detect specif-
ic anti-Tsal antibodies induced by various tsetse fly species in a range of hosts. We propose
that this competitive assay provides a simple serological indicator of tsetse fly presence
without the requirement of test adaptation to the vertebrate host species. In addition, the
use of monoclonal Nbs for antibody detection is innovative and could be applied to other
tsetse fly salivary biomarkers in order to achieve a multi-target immunoprofiling of hosts. In
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addition, this approach could be broadened to other pathogenic organisms for which accu-
rate serological diagnosis remains a bottleneck.
Author Summary
Our previous studies have revealed that the saliva of the savannah tsetse fly (Glossina mor-
sitans morsitans) and the main constituting Tsal proteins are sensitive immunological
probes to detect contact with tsetse flies. A nanobody (Nb) library was generated against
tsetse salivary gland proteins and used to select Nbs against the highly immunogenic Tsal
proteins by a procedure of phage display and selection for binding onto the recombinant
Tsal proteins. One Nb family was identified with the appropriate characteristics for the de-
velopment of a competitive assay to detect Tsal-specific antibodies raised by the mammali-
an host when exposed to tsetse fly bites. In this immunoassay, exposure was detected by
the inhibition of Nb binding by tsetse fly saliva induced antibodies in plasma. Evaluation
of the competitive ELISA test using a set of porcine plasmas revealed an improved accura-
cy as compared to previously described tests. Moreover, the advantage of this assay is that
it does not require adaptation to the sampled host species. We propose the Nb-based com-
petitive ELISA as an additional tool to the indirect ELISA to serologically detect tsetse bite
exposure and to monitor the impact of vector control programs and to detect re-invasion
of cleared areas by tsetse flies on the African continent. In addition, the concept of using
Nbs for the development of competitive antibody detection tests is innovative and broad-
ens the scope of medical diagnostic applications of Nbs.
Introduction
Control of the tsetse fly vector population represents an important component of the fight
against Human and Animal African Trypanosomiasis (HAT and AAT). In addition to the im-
plementation of conventional vector control interventions, alternative strategies [e.g. miniatur-
ized insecticide-treated targets [1], the release of sterile male insects [2,3]] are being deployed
on increasingly large scales on the African continent. With the HAT elimination phase in sight
[4,5], adequate monitoring of the evolution of tsetse fly densities in areas under tsetse control is
a necessity. Here, sero-epidemiological surveys based on tsetse salivary proteins could allow
convenient monitoring of tsetse fly exposure on a regular basis and reveal the efficacy of ap-
plied and/or ongoing tsetse fly control activities [reviewed in [6]].
Studies using various tsetse fly species have shown that salivary components are immuno-
genic in mice, rabbits, cattle and humans with the induction of antibodies [7–12]. The secreted
saliva proteome (or sialome) of the most studied tsetse species, Glossina morsitans morsitans, is
predicted to contain more than 200 different protein constituents [13] from which some were
described to support the blood feeding physiology [14,15]. Immunoblotting of salivary proteins
provided evidence for the immunogenicity of several of the major protein families including
endonuclease (Tsal), adenosine deaminase (TSGF), 5’nucleotidase (5’Nuc) and Antigen 5
(Ag5) related proteins [7,8]. In addition, immune screening of a phage salivary gland cDNA ex-
pression library resulted in the identification of the immunogenic G.m.morsitans salivary
gland proteins sgp1, sgp2 and sgp3 [16]. A number of potential candidates were proposed as in-
dividual exposure biomarkers in the form of recombinant proteins or peptides corresponding
to predicted B cell epitopes [17,18]. The TSGF118–43 peptide was shown in West Africa to
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detect human antibody levels that correlated with the anticipated levels of tsetse exposure [17].
Especially the 43–45 kDa tsetse salivary gland (Tsal) protein family, encoded by 3 tsal genes
that colocalize to a 10-kb locus in the tsetse fly genome [19], was found to be highly immuno-
genic with immunoglobulin responses detected in humans living in Uganda [7], Democratic
Republic of Congo [10] and Guinea [8]. Corroborating the high immunogenicity, exposure of
mice to a single tsetse bite was sufficient to induce detectable levels of anti-Tsal antibodies in
plasma. Moreover, murine antibody titers persisted long and remained detectable up to one
year after initial challenge [18]. Further exploiting the highly immunogenic nature of the Tsal
proteins, rTsal1 was evaluated as antigen in an indirect ELISA test and shown adequate to de-
tect tsetse induced antibody responses in experimentally exposed pigs [18].
With the advent of Nanobody (Nb) technology, the generation of an expression library of
monoclonal antigen-binding antibody fragments directed against the tsetse salivary proteome
was enabled for protein functional studies. Nbs are moieties of approximately 15 kDa derived
from Heavy-chain Antibodies that are present in Camelidae [20] and can be selected through
phage-display technology and an array of panning methodologies. Nbs are excellent affinity re-
agents with a small size, high stability, particular epitope range as compared to conventional
antibodies, reversible refolding capacity and high solubility in aqueous solutions. Due to these
favorable biochemical and biophysical properties, Nbs are increasingly exploited in protein
structure/function studies and in the development of medical diagnostic and therapeutic appli-
cations (reviewed in ref [21]). Here we report on the selection of a particular Nb family from
the anti-tsetse sialome Nb library that is able to mark the presence of anti-Tsal antibodies in
plasmas of tsetse fly exposed animals using a competitive ELISA format. Performance of this
novel assay is compared with the previously reported indirect antibody detection assay.
Methods
Ethics statement
Alpaca immunization and blood collection was performed by the Nanobody Service Facility,
VIB. Breeding and experimental work with tsetse flies was approved by the Scientific Institute
Public Health department Biosafety and Biotechnology (SBB 219.2007/1410). The experi-
ments, maintenance and care of animals complied with the guidelines of the European Con-
vention for the Protection of Vertebrate Animals used for Experimental and other Scientific
Purposes (CETS n° 123).
Plasmas
Plasma from tsetse fly exposed hyperimmune rabbits was collected in the frame of another
study [16]. Mouse plasmas (n = 5/group) were available from a previous tsetse fly cross-reactiv-
ity study [18], where mice were exposed every 3 days for 6 weeks to 10 flies of either G. p. gam-
biensis, G. pallidipes or G. f. fuscipes. Plasma samples were also collected earlier from mice
intradermally immunized with decreasing amounts of saliva (5, 2, 1 and 1 μg) harvested from
G.m.morsitans, Stomoxys calcitrans and Tabanus yao. Immune plasmas were collected 10
days after the last exposure. Plasmas obtained from non-exposed mice served as
negative controls.
Porcine plasma samples were obtained previously from a total of 10 female pigs exposed to
three different G.m.morsitans exposure regimens (high exposure, low exposure and negative
control) [18]. From those animals, pre-immune plasmas were collected and samples were col-
lected for 11 successive weeks and after a 2-month period of non-exposure, 2 pigs from the low
exposure group were re-challenged by the bites of 10 G.m.morsitans flies followed by weekly
plasma collection over a period of 6 weeks.
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Salivary antigens and recombinant proteins
Total G.m.morsitans saliva was obtained as salivary gland outflow from 300 gland pairs incu-
bated for 2h on ice in a sterile physiological salt solution. Saliva was collected as the supernatant
after a 2 min. centrifugation at 500 × g at 4°C. The saliva protein concentration was determined
by the BCA protein assay kit (Pierce Biotechnology) and aliquots for immunization and pan-
ning were stored at-80°C.
Salivary gland membrane extracts were prepared from approximately 1200 G.m.morsitans
salivary gland pairs from which the saliva outflow was removed. Salivary glands were sonicated
in 10 ml phosphate buffered saline (PBS) containing a protease inhibitor mix (Complete,
Roche). The supernatant obtained after 30’ centrifugation at 100000 × g at 4°C was a salivary
gland soluble extract. The salivary gland membrane extract was prepared by resuspending the
pellet in 2 ml 2% octyl-β-D-glucopyranoside (in PBS) followed by a 30’ centrifugation at
100000 × g at 4°C. The supernatant was collected as the salivary gland membrane extract. The
membrane extract was dialysed twice against 250 ml PBS containing 0.05% octyl-β-D-gluco-
pyranoside. Composition was analyzed by protein gel electrophoresis and Coomassie staining.
Aliquots for immunization and panning were stored at-80°C.
Recombinant proteins Tsal1 and Tsal2 were purified as described elsewhere from the peri-
plasm of bacterial expression clones using Ni-NTA superflow affinity chromatography (Qia-
gen) and Superdex 200 gelfiltration chromatography on an Äkta Explorer (GE Healthcare)
[22]. Aliquots were stored at −20°C till further use.
Alpaca immunization and anti-tsetse sialome Nb-library construction
An alpaca was used for immunization with G.m.morsitans saliva and salivary gland mem-
brane extract on contralateral sites of the alpaca body at weekly intervals for six consecutive
weeks by injections of 100 μg salivary gland membrane extract and 100 μg saliva in presence of
Gerbu adjuvant. Peripheral blood was taken four days after the last injection for the isolation of
blood lymphocytes and to assess the antibody response against the salivary antigens. Conven-
tional and heavy chain antibodies were purified from the plasma by protein A and protein G
sepharose affinity chromatography. Conventional IgG1 antibodies were purified using protein
G sepharose, a wash step with 150 mMNaCl 0.58% acetic acid pH 3.5 to remove IgG3 and an
elution using 100 mM glycine-HCl pH 2.7. Heavy chain IgG2 was purified by a negative selec-
tion on protein G sepharose and a purification with protein A sepharose followed by a selective
elution at pH 3.5. As controls, the same IgG fractions were also purified through the same pro-
cedure from an alpaca immunized against a non-related antigen. Reactivity of the purified anti-
bodies was evaluated in an indirect ELISA developed using an in-house rabbit anti-camel
polyclonal IgG and a peroxidase-conjugated anti-rabbit IgG (Sigma).
Lymphocytes were isolated from peripheral blood ½ diluted in RPMI1640 using Lympho-
prep (Nycomed). RNA was extracted using Trizol reagent and cDNA was prepared from 40 μg
total RNA for the construction of the anti-salivary gland immune Nb library. VHH gene frag-
ments ranging from codons from framework region 1 to framework region 4 were amplified by
nested PCR. The first PCR round (32 cycles 1’ at 94°C, 1’ at 55°C and 1’ at 72°C) was performed
with primers callI (5’-GTCCTGGCTGCTCTTCTACAAGG-3) and callII (5’-GGTACGTGCT
GTTGAACTGTTCC-3’). PCR products were separated on a 2% agarose gel and the 700 bp
band corresponding to the amplified VHHs fragments was excised from gel and purified using
the QIAquick gel extraction protocol (Qiagen). Using this purified product as template, the
2nd round PCR was performed using the same PCR conditions as mentioned above with
primers A6E (5’-GATGTGCAGCTGCAGGAGTCTGGRGGAGG-3’) and pmcf (5’-CTAGT
GCGGCCGCTGAGGAGACGGTGACCTGGGT-3’). Nested PCR products and the pMECS
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phagmid, derived from pHEN4, were digested with PstI and NotI. A total of 17.6 μg of pMECS
vector and 18.6 μg of insert were used in the ligation reaction and subsequently transformed
with a 1.8 kV pulse into electrocompetent Escherichia coli TG1 cells (Immunosource). Electro-
porated cells were collected in recovery medium (Immunosource) and plated on LB agar plates
supplemented with 2% glucose and 100 μg/ml ampicillin. Dilutions were plated to determine
the library size and to determine insert frequencies based on a colony PCR (32 cycles 1’ at 94°C,
1’ at 55°C and 1´ at 72°C) using primersMP57 (5’-TTATGCTTCCGGCTCGTATG-3’) and GIII
(5’-CCACAGACAGCCCTCATAG-3’). The library was collected in LB-medium supplemented
with 20% glycerol, aliquoted and stored at −80°C.
Selection, purification and HRP-labeling of Tsal-specific Nbs
The anti-tsetse sialome library was expressed on phages and obtained by super-infection of the
phagemid-containing TG1 cells with M13K07 helper phages (Invitrogen). Libraries were en-
riched by four consecutive rounds of in vitro selection on a equimolar mix of recombinant
Tsal1 and Tsal2 (500 ng/well each, 1 μg in total), immobilized in NUNCMaxiSorp plates
(Thermo Scientific). Phages were eluted under alkaline conditions with 100 mM triethylamine
(~ pH 11.5), followed by an immediate pH neutralization by 1:1 addition of 1 M Tris pH 7.4
and amplification of eluted phages in E. coli TG1 cells. Enrichment of the library was assessed
by a Tsal1&2-specific phage ELISA using a horseradish peroxidase-conjugated anti-M13
antibody (Amersham Biosciences). Individual colonies of transfected TG1 cells from the third
panning round were picked to evaluate the expression of Tsal-specific Nbs upon induction
with 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG). Binding was evaluated onto recombi-
nant Tsal1&2 (500 ng/well each) and native Tsal proteins in G.m.morsitans saliva (1 μg/well).
Detection was with a peroxidase-conjugated mouse anti-HA IgG1 (HA.11 Clone 16B12, BioLe-
gend) and with TMB substrate (3,30,5,50-Tetramethylbenzidine, Sigma). Reactions were
stopped by the 1:2 addition of 1 N H2SO4 and optical densities (O.D.) were measured using a
Multiskan Ascent plate reader (Thermo) at a 450 nm wavelength.
Tsal-specific clones were subjected to sequence analysis (Genetic Service Facility, VIB).
Translated sequences were aligned using the CLUSTALW program and imported into Gene-
Doc (http://www.psc.edu/biomed/genedoc). Aligned sequences were imported in Mega 5 and
consensus maximum likelihood trees were built using the standard settings and 500
bootstrap replications.
Clones of interest were used for Nb purification directly from TG1 cells. Expression was in-
duced overnight at 28°C with 1 mM IPTG, Nbs were purified from periplasmic bacterial ex-
tracts with Ni-NTA columns (Qiagen) using 0.5 M imidazole/PBS as elution buffer followed by
purification by size exclusion chromatography on a Superdex 75 10/300 GL column (GE Healt-
care) with phosphate buffered saline (PBS) as running buffer. Protein concentrations were de-
termined by the optical density at 280 nm and the individual theoretical extinction coefficients
calculated using the ProtParam webtool. Nbs were aliquoted and stored at-20°C until
further use.
Nanobodies were labeled by use of EZ link Plus Activated Peroxidase (Thermo Scientific).
Conjugation reactions were carried out for 1h at room temperature at pH 7.2, followed by
quenching the reaction and purification by size exclusion chromatography on a Superdex 75
10/300 GL column. Conjugates were stored at 4°C.
Nanobody binding kinetics and affinity determination
To evaluate the binding kinetics of selected Nbs for the native Tsal proteins, 4000 resonance
units (RU) corresponding to approximately 4 ng/mm² of G.m.morsitans saliva was coupled in
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10 mM sodium acetate pH 4.5 onto a CM5 chip (BIAcore) using EDC and NHS as cross-link-
ing agents and ethanolamine to block free esters. The individual purified Nb analytes were test-
ed in concentrations ranging from 500 to 0.976 nM on a BIAcore T200 apparatus. Contact
time was for 180 s, dissociation for 600 s at a 10 μl/min flow rate. Chip regeneration was
achieved with 2 pulses of 10 s with 100 mM glycine-HCl pH 2.2 at a 30 μl/min flow rate. Senso-
grams were fitted for a Langmuir 1:1 binding model using the BIAcore T200 evaluation soft-
ware version 1.0, resulting in association and dissociation constants (ka and kd) as output from
which affinity (KD) values were calculated. χ
2 values and residuals were analyzed for accuracy
of the fitting. Epitope mapping was performed on the CM5-G.m.morsitans saliva sensor chip
by evaluating cumulative or competitive binding of two-by-two Nb combinations at a 500
nM concentration.
Steady state affinities were also evaluated by ELISA where Nbs were applied to G.m.morsi-
tans saliva coated wells and detected using the HRP-conjugated anti-HA Tag antibody and
TMB as substrate. Responses to the antigen (O.D.450nm values) were fitted to a one-site binding
non-linear regression model in the GraphPad Prism 5.02 software package with Bmax and KD
values as output parameters.
Serological analyses
Polystyrene 96 well plates (NUNCMaxiSorp™ Surface, Thermo Scientific) were coated for 1h
at ambient temperature with 250 ng G.m.morsitans saliva in 0.1 M NaHCO3 (pH 8.3) in each
well. Plates were overcoated for 1 h with 10% fetal bovine serum (FBS) at ambient temperature.
Diluted or undiluted plasma samples were applied for 1 h. Next, plates were incubated for 1h
with appropriate dilutions (1:160 or 1:320) of the HRP-conjugated Nbs in PBS. Detection was
with ABTS substrate (KPL) and optical densities were measured using the Multiskan Ascent
plate reader at a 405 nm wavelength.
Data analysis
Competitive ELISA results were expressed as endpoint O.D.405nm values after 30 min incuba-
tion (within the semi-linear phase of substrate conversion). Percentage inhibition was calculat-
ed from the rate of substrate conversion (ΔO.D.405nm/min) relative to the activity recorded in
wells with control plasmas (100% activity). Inhibition of Nb binding as evaluated by two-way
analysis of variance and pairwise comparisons were performed using a Bonferroni post-test.
Cross-reactivity of immune responses induced by different Glossina species and other hema-
tophagous insects was analysed using a one-way analysis of variance and Tukey’s multiple
comparisons technique. Graphs were prepared using the GraphPad Prism 5.02 software pack-
age. Data represented in the graphs are the means and the 95% confidence intervals (CI).
Competitive ELISA results for the two selected Nb candidates (Nb-Tsal-05 and Nb-Tsal-11)
were compared by the non-parametric Spearman correlation test using GraphPad Prism 5.02
with Spearman correlation coefficient (r) as output. Performance of the assays was assessed by
receiver operating characteristic (ROC) curve analysis of the endpoint O.D.405nm values of
non-exposed animals (21 control plasmas, including 9 pre-immune and 12 repeated samplings
of the control pig) and exposed animals 3 weeks after the initial exposure (90 plasmas obtained
by repeated sampling of the 9 exposed pigs). The area under the ROC curve (AUC) was used as
a global index of diagnostic accuracy. To compare the assays with the previously described G.
m.morsitans and rTsal1 based indirect ELISA [18], we have calculated sensitivity, specificity,
positive and negative predictive values and accuracy on the basis of the same set of 111 porcine
plasmas used to make the ROC curve analysis. Positive samples were identified based on cut-
off values calculated using a Student t-distribution according to Frey et al. [23]. For the indirect
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ELISA, the upper prediction limit was determined with following formula using a 95% confi-
dence level:





For the competitive ELISA, the lower prediction limit was used as cut-off, calculated as fol-
lows:






Generation of an anti-tsetse sialome Nb library and selection of Tsal-
specific Nbs
Immunization of an alpaca against soluble saliva antigens and the salivary gland membrane
proteins resulted in strong antibody responses, both in the conventional (IgG1) and heavy
chain antibody (IgG2) isotypes as determined by an indirect ELISA. A Nb library was con-
structed from the peripheral blood lymphocytes of the immunized alpaca by a VHH-specific
nested RT-PCR and by ligation of the obtained inserts into the phagemid vector pMECS. The
generated library had a size of 1.3 107 individual transformants for which it was estimated that
80% harboured the vector with an insert of the correct size as determined by colony PCR. Four
consecutive panning rounds were performed on solid phase immobilized recombinant Tsal1
and Tsal2 with a clear enrichment recorded by phage ELISA (Fig. 1A). A total of 12 different
clones (TsalNb1–12) belonging to three Nb families (I—III) were identified based on sequence
variations in the complementarity determining regions CDR-1 and CDR-3 (Fig. 1C). Periplas-
mic extract ELISA revealed variations in binding profiles of the different Nb families (Fig. 1B),
with family II displaying a nearly exclusive preference for the recombinant form of the Tsal
proteins and Nb family III the highest antigen/overcoat O.D. ratio in favour of the native Tsal
proteins in G.m.morsitans saliva. Surface plasmon resonance (SPR) analysis was used to ob-
tain kinetic data of binding of family I and III TsalNbs onto the native Tsal proteins in G.m.
morsitans saliva (Fig. 2A&B). Consistent with the ELISA results, family II TsalNbs were achiev-
ing very low binding responses in SPR with affinities in the micromolar range. Without em-
phasizing on the absolute values calculated for the affinity and kinetic rate constants for the
interaction between the Nb analytes and the heterogenous saliva ligand, family I TsalNbs con-
sistently dissociated slower from their antigenic target (with smaller kd dissociation constants)
as compared to family III TsalNbs (Table 1, Fig. 2A&B). Results obtained by SPR kinetic analy-
ses (Table 1) and binding studies performed by ELISA (Fig. 2C) are compatible with affinities
in the high picomolar range for the family I TsalNbs and in the low nanomolar range for the
family III TsalNbs. The highest binding responses in SPR and ELISA were obtained with
TsalNb-5 and TsalNb-11 of TsalNb family III. Epitope mapping by SPR revealed cumulative
binding of TsalNb1 and TsalNb11, demonstrating that Nbs of families I and III bind to distinct
epitopes (Fig. 2B, inset).
Development of a Nb-based competitive immunoassay
Representatives of the 3 Tsal Nb families (TsalNb-1, TsalNb-9 and TsalNb-5,8&11) were
chemically conjugated to horseradish peroxidase (HRP), purified by size exclusion chromatog-
raphy to remove unlabeled Nb and used as detection moieties in the G.m.morsitans saliva
based ELISA assay. Evaluation of the inhibition of Nb binding by immune plasma from tsetse
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fly exposed rabbits, provided strong statistical support for a significant competition with
TsalNb-5,8&11 (p< 0.001, Fig. 3), representatives of TsalNb family III. To confirm the poten-
tial of TsalNb family III for the development of a competitive anti-Tsal antibody detection
assay, the two different Nbs with the highest naive/immune O.D. ratios—TsalNb-5 and
TsalNb-11—were HRP conjugated in an independent labeling reaction and purified (S1A Fig.),
titrated to determine the optimal working Nb-HRP dilution (S1B Fig.) and evaluated in a com-
petitive assay using various rabbit serum concentrations (S1C Fig.). A strong inhibition of Nb
binding by the immune serum was observed for the two Nb-HRP conjugates.
Cross-reactivity profile of the Nb-based competitive immunoassay
In order to evaluate the cross-reactivity with other tsetse fly species, mouse plasmas immunized
against the saliva of various Glossina species (G. p. gambiensis, G. pallidipes and G. f. fuscipes)
were tested in the competitive immunoassay using TsalNb-5-HRP and TsalNb-11-HRP. A
marked cross-reactivity of the anti-saliva antibodies elicited by the three Glossina species (G. p.
gambiensis and G. pallidipes, G. f. fuscipes; p< 0.001) was detected (Fig. 4A&B). Only one G. f.
fuscipes exposed animal was scored as false negative on the basis of a cut-off determined from
the control samples. No false positive reactions were observed in any of the control animals.
In order to evaluate cross-reactivity with other hematophagous insects, mouse plasmas ex-
posed to the saliva of stable flies (Stomoxys calcitrans) or horse flies (Tabanus yao) and samples
from control mice and mice that were immunized with G.m.morsitans saliva following the
same immunization protocol were tested. Immunization with Stomoxys and Tabanus saliva
did not result in antibodies that false positively reacted in the competitive assay indicating that
the assay is tsetse fly specific (Fig. 4A&B).
Figure 1. Selection of Tsal-specific Nbs from the anti-tsetse sialome Nb library. (A) Enrichment of Tsal-specific phages during the different panning
rounds as determined by phage ELISA. (B) ELISA to detect Tsal-specific Nb-binding activity in periplasmic extracts of individual clones. Binding was
evaluated onto the immobilized recombinant Tsal1 and Tsal2 and onto native Tsal in totalG.m.morsitans saliva. (C) Amino acid sequences of the 12
identified TsalNb clones with the corresponding maximum likelihood consensus tree. Three Nb families were identified based on sequence variations in
CDR-1 and CDR-3 (TsalNb families I, II and III) with different binding properties as observed in the periplasmic extract ELISA. Dots in the alignment represent
conserved amino acid positions.
doi:10.1371/journal.pntd.0003456.g001
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Figure 2. Functional characterization of the Tsal-specific Nbs. (A) Surface plasmon resonance experimental (SPR) sensograms (solid line) and the fitted
data (dotted line) obtained for different TsalNb analyte concentrations (15.125–0.976 nM) with 4000 RUG.m.morsitans saliva immobilized on a CM5 chip.
Upper panel are sensograms for TsalNbs of family I, lower panel those of family III. (B) Dot plot representation with isoaffinity lines of the individual ka, kd and
KD affinity constants (see Table 1) of the different TsalNbs as determined by SPR. Blue symbols represent TsalNbs of family I, red symbols represent
TsalNbs of family III. Inset: epitope mapping of TsalNb-1 (family I) and TsalNb-11 (family III) in SPR, revealing cumulative binding reminiscent of a different
epitope recognition (C) Binding studies in ELISA with purified TsalNbs-1–12 (TsalNb families I, II and III shown in blue, green and red respectively) onto solid
phase immobilizedG.m.morsitans saliva detected using an HRP-conjugated anti-HA Tag antibody.
doi:10.1371/journal.pntd.0003456.g002
Table 1. Characteristics of the selected anti-Tsal Nbs.
Nb family ID ka (M
-1s-1) kd (s
-1) KD (M)
I TsalNb-1 8,5E+05 3,7E-04 4,4E-10
TsalNb-2 1,2E+06 7,7E-04 6,4E-10
TsalNb-3 9,3E+05 5,1E-04 5,4E-10
TsalNb-4 1,1E+06 5,0E-04 4,4E-10
TsalNb-10 1,3E+06 1,0E-03 7,9E-10
TsalNb-12 8,3E+05 3,9E-04 4,7E-10
III TsalNb-5 9,1E+05 4,0E-03 4,4E-09
TsalNb-8 9,7E+05 1,7E-02 1,8E-08
TsalNb-11 1,3E+06 3,5E-03 2,7E-09
The afﬁnity and kinetic rate constants determined by surface plasmon resonance on a CM5-G. m.
morsitans saliva chip with the TsalNbs of families I and III.
doi:10.1371/journal.pntd.0003456.t001
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Evaluation of the Nb-based competitive immunoassay in pigs exposed
toG.morsitans bites
Plasma samples were previously collected from pigs that were experimentally exposed to a low
or a high tsetse fly bite regimen. Titration studies using plasma collected at the peak of anti-
Tsal1 and anti-G.m.morsitans saliva antibody responses as determined earlier [18], indicated
that best competition was obtained with undiluted porcine plasma (p< 0.05; S2 Fig.). Evalua-
tion of the anti-Tsal responses over time with the competitive assay revealed similar kinetics as
determined earlier with the G.m.morsitans saliva and rTsal1 based indirect ELISA. A steady
decline in antibody titers was observed upon cessation of tsetse exposure (Fig. 5A&B). Howev-
er, unlike the indirect ELISA, competitive ELISA test results did not correlate significantly with
the intensity of tsetse exposure. Boosting of two immunized pigs from the low exposure group
after a 2-month non-exposure period by the bites of 10 flies resulted in elevated anti-saliva an-
tibody titers that were detectable in the competitive immunoassay (Fig. 6A&B). A good correla-
tion between the TsalNb-5-HRP and TsalNb-11-HRP based tests was recorded with a
Spearman correlation coefficient r of 0.95 (S3A Fig.). Area under the ROC curve (AUC = 0.99,
S3B Fig.) for the TsalNb-5-HRP and TsalNb-11-HRP immunoassays were very high and ex-
ceeded AUCs that we reported previously for the porcine indirect ELISA using respectively
Figure 3. Competitive inhibition of TsalNb binding by immune plasma. Representatives of the identified
anti-Tsal Nb families (TsalNb-1, TsalNb-9 and TsalNb-5,8&11) were covalently conjugated to HRP and
evaluated for Tsal-binding (O.D.405nm) following incubation of the coatedG.m.morsitans saliva with tsetse
exposed immune or naive rabbit plasma. Significance levels based on two-way analysis of variance are
indicated in the graphs (*** p<0.001).
doi:10.1371/journal.pntd.0003456.g003
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G.m.morsitans saliva and rTsal1 as coating antigens (AUC = 0.96 and 0.83, [18]). Given the
absence of a gold standard, we made a comparison of the new competitive test with the previ-
ously described indirect ELISA tests in terms of sensitivity, specificity, positive and negative
Figure 4. Cross-reactivity profile of the Nb-based competitive immunoassay. Plasmas of control mice and mice repeatedly exposed to the bites of
various tsetse species (G. palpalis gambiensis,G. pallidipes andG.fuscipes fuscipes) and mice intradermally immunized with harvestedG.m.morsitans,
Stomoxys calcitrans and Tabanus yao saliva were analysed for anti-Tsal antibody responses in the competitive ELISA using TsalNb-5-HRP (A) and TsalNb-
11-HRP (B) as detection reagents. The mean endpoint O.D.405nm of controls were 2.260 and 2.354 following detection with respectively TsalNb-5-HRP and
TsalNb-11-HRP. Presented data are the mean percentage inhibition relative to the controls with the 95% CI. Significance levels based on one-way analysis
of variance are indicated in the graphs (*** p<0.001).
doi:10.1371/journal.pntd.0003456.g004
Figure 5. Detection of humoral responses in experimentally exposed pigs. Follow-up of the anti-Tsal antibody responses in pigs exposed to 2 different
tsetse fly biting intensities [two-weekly exposure for 6 weeks to 3 flies (low exposure group, n = 4) or weekly exposure for 7 weeks to 30 flies (high exposure
group, n = 5)] in the competitive ELISA using TsalNb-5-HRP (A) and TsalNb-11-HRP (B) as detection reagents. Samples from one non-exposed animal were
available as negative controls. The mean endpoint O.D.405nm of controls were 2.315 and 2.240 following detection with respectively TsalNb-5-HRP and
TsalNb-11-HRP. Presented data are the mean percentage inhibition relative to the controls with the 95% CI obtained for undiluted plasmas.
doi:10.1371/journal.pntd.0003456.g005
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predictive values (PPV and NPV) and accuracy determined for the available set of experimen-
tally exposed porcine plasmas (nexposed = 90, nnon-exposed = 21, Table 2). These analyses showed
that all assays under their specific test conditions had very good specificities (> 95%) and
Figure 6. Detection of boosting in pigs after a period of non-exposure. Evolution of the anti-Tsal
antibody responses in the competitive ELISA using TsalNb-5-HRP (A) and TsalNb-11-HRP (B) was
evaluated in pigs (n = 2) originally exposed two-weekly for 6 weeks to the bites of 3 flies (= low exposure
group) and re-exposed to the bites of 10 flies (indicated by an arrow) after a 2-month period of non-exposure.
One non-exposed animal sampled during the priming experiment (Fig. 5) served as a negative control. The
mean endpoint O.D.405nm of controls were 2.235 and 2.291 following detection with respectively TsalNb-5-
HRP and TsalNb-11-HRP. Presented data are the percentages inhibition relative to the controls obtained for
the plasmas of the individual pigs.
doi:10.1371/journal.pntd.0003456.g006
Table 2. Comparison of the test characteristics of the novel competitive ELISA and the previously described indirect immunoassays with the
available set of porcine plasmas.
Indirect ELISA Competitive ELISA
G.m.m. saliva rTsal1 TsalNb-8-HRP TsalNb-11-HRP
nexposed 90 90 90 90
nnon-exposed 21 21 21 21
Cut-off O.D. 95% CL 0,202 0,212 2,145 2,066
TP 79 51 87 86
TN 20 20 20 20
FP 1 1 1 1
FN 11 39 3 4
Sensitivity 87,8% (79/90) 56,7% (51/90) 96,7% (87/90) 95,6% (86/90)
Speciﬁcity 95,2% (20/21) 95,2% (20/21) 95,2% (20/21) 95,2% (20/21)
PPV 98,8% (79/80) 98,1% (51/52) 98,9% (87/88) 98,8% (86/87)
NPV 64,5% (20/31) 33,9% (20/59) 87,0% (20/23) 83,3% (20/24)
Accuracy 89,2% (99/111) 64,0% (71/111) 96,4% (107/111) 95,5% (106/111)
Respective ELISA results for a set of 90 tsetse exposed (10 repeated samplings of the 9 exposed pigs starting three weeks after the initial exposure) and
21 non-exposed porcine plasmas (9 pre-immune and 12 repeated samplings of the control pig) were interpreted based on the calculated cut-off values
(see methods section). TP true positive, TN true negative, FP false positive, FN false negative, PPV positive predictive value, NPV negative
predictive value.
doi:10.1371/journal.pntd.0003456.t002
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PPVs (> 98%). However, the competitive assay appeared to result in less false negative diagno-
ses, resulting in higher NPVs and hence increased sensitivity (> 95%) and accuracy (> 95%).
Discussion
The concept of exploiting salivary components as specific biomarkers of exposure of verte-
brate host to bites of medically important arthropods has been proposed for a number of spe-
cies of sand flies [24–26], triatomine bugs [27,28], mosquitoes [29–31] and also tsetse flies
[7,8,10–12,17,18]. The main added value of such approach is that relatively simple serological
tests could indicate actual exposure to the bites of disease vectors without the requirement of
conducting strenuous entomological surveys. Beside serving as a risk indicator for infection
with a vector-transmitted pathogen, this approach might reveal low levels of exposure that
are undetectable by entomological trappings [32] and allow the monitoring of the efficacy of
control interventions [24,30,33,34]. This saliva biomarker approach can be performed at the
population-level or can be limited to individual serological follow-up of selected animals or
sentinel animals.
In this study we have improved and simplified the detection of tsetse fly induced antibody
responses against the Tsal protein family. This was realized by converting the indirect ELISA
for Tsal antibody detection that we described previously [18] into a competitive assay format
using anti-Tsal nanobodies (Nbs). For this, Tsal-specific Nbs were selected from an anti-G.m.
morsitans sialome Nb-library using the recombinant versions of the Tsal proteins that we pre-
viously described to exert high affinity nucleic acid binding activity [22]. A total of three Nb
families were identified from the anti-sialome Nb library, including two (family I and III) that
reacted with different epitopes on the native Tsal proteins. Both Nb families did not react with
the rTsal1 protein that was purified under denaturing conditions and that we previously char-
acterized as coating antigen in the indirect ELISA [18], suggesting that these Nbs recognize
conformational epitopes. Two Nbs of family III (TsalNb-5 and TsalNb-11), conjugated to
HRP, displayed the best binding characteristics and achieved the best results in a competitive
assay that was first tested using plasma of tsetse saliva hyperimmune rabbits. Indeed, these two
particular Nb candidates achieved highest maximal binding responses in the ELISA and SPR
studies, displayed moderate dissociation constants and were efficiently displaced by the poly-
clonal host antibodies in a competitive assay. The absence of efficient competition with family I
TsalNbs could result from a targeted epitope that might not overlap with those of polyclonal
antibodies induced by tsetse fly exposure and/or by the very slow dissociation rate that might
hamper efficient Nb-HRP displacement. Following the pilot experiments with rabbit hyperim-
mune plasma, TsalNb-5-HRP and TsalNb-11-HRP were further evaluated with a panel of
available murine and porcine plasmas of tsetse exposed animals.
Analysis of mouse plasmas exposed to different tsetse fly species revealed a broad range of
detection of the competitive assay, including exposure to G. f. fuscipes. This confirmed our pre-
vious observation that the Tsal antigens are sufficiently conserved in the saliva of several Glos-
sina species to allow multi-species detection of exposure [18], which was achieved with this
new competitive immunoassay. Exposure of mice to the saliva of other hematophagous insects
(Tabanus and Stomoxys sp.) that are known to be abundant in areas where tsetse flies are pres-
ent, revealed that the competitive assay does not cross-react with those insect species. This fea-
ture has also been documented for the G.m.morsitans saliva and rTsal-based indirect ELISA
tests [18]. Observations in cattle exposed to Stomoxys and Tabanus bites revealed that also G.
m. submorsitans saliva shares this feature of specificity, unlike Glossina tachinoides and G. pal-
palis gambiensis saliva [12]. These observations further supported the concept that the Tsal an-
tigens in G.morsitans saliva are suitable antigenic targets for specific pan-tsetse species
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exposure detection. Moreover, the detection of responses against a specific diagnostic epitope
on the Tsal proteins in the competitive assay strongly reduces the possibility of unspecific reac-
tions, a principle that is also aimed at by immunoassays that use synthetic peptides [17]. The
use of total saliva as crude antigen in this assay might be a drawback for two main reasons: (i)
the production and (ii) possible issues with specificity. Given that G.m.morsitans colonies
exist at various locations in the world and that the harvesting of saliva can be relatively straight-
forward and with high yields, this is not necessarily a problem. Production of folded, biological-
ly active Tsal proteins in the periplasm of E. coli is possible, but yields are very low due to
cytotoxicity that is probably linked to the DNA-binding/endonuclease activity of the properly
folded Tsal proteins [22]. Other strategies for the efficient production of these proteins, e.g. in
insect cells, could be envisaged. Related to the issues of specificity, the detection moiety (a Nb
directed against a single diagnostic epitope) circumvents problems of specificity encountered
with crude antigens. Indeed, epitopes are presented in the natural conformation and displace-
ment of high affinity Nbs disfavors detection of low affinity cross-reactive antibodies. An ad-
vantage of using total saliva is that it could also serve as an antigen in competitive ELISAs
using nanobodies against other antigenic targets, enabling a multi-epitope immunoprofiling.
This competitive assay has the additional advantage that given the particular assay type, no
modifications are required to detect antibodies across host species. Indeed, given particular is-
sues with porcine IgG detection, E. coli soluble extract had to be added to the sample diluent to
increase assay specificity of the rTsal1 and G.m.morsitans saliva based indirect ELISAs [18].
In combination with the prescribed 1:1600 plasma dilution, these required stringent assay con-
ditions for the indirect antibody detection test ensured very good specificities and positive pre-
dictive values, exceeding 95% and 98% respectively, but resulting in a reduced negative
predictive value and sensitivity. The competitive ELISA did not require this sample treatment
and dilution, enhancing the detection of antibodies in pigs exposed to the low exposure regi-
men. Although the competitive test was unable to differentiate the responses against the one
particular diagnostic epitope induced by the low and high exposure regimen, a steady decline
in antibody titers could be detected upon cessation of tsetse exposure. A comparison of the
competitive assay performance to the previously described assays using an available panel of
21 exposed and 90 non-exposed porcine plasmas revealed less false negative diagnoses and
an improved negative predictive value (83–87%), sensitivity (> 95%) and accuracy of the test
(> 95%). Estimation of the real test characteristics will require evaluation in the field on a
larger scale.
The general diagnostic usefulness of competitive ELISAs is well established and is exemplified
by the commercialization of various antibody detection tests for e.g. Rift Valley fever, foot-and-
mouth disease, West Nile virus and avian influenza infections that make use of conventional
monoclonal antibody technology. In this study we have broadened the scope of application of
Nbs by illustrating that they can be used in competitive antibody detection tests. The ease of
selecting suitable diagnostic Nbs through phage display and panning provides a promising al-
ternative to monoclonal antibody technology in diagnostic test development. There are already
a number of examples of the use of Nbs for the specific detection of components in complex
mixtures. For instance, Nbs have been selected with the appropriate characteristics to evaluate
the presence of a diagnostic glycoprotein of Taenia solium cysticerca in porcine serum [35],
to quantify prostate-specific antigen in spiked human serum [36] and to detect the fungal afla-
toxin in organic food extracts [37]. However, Nbs had not yet been used for the detection of
antibodies. The reason for this is that it is generally assumed that Nbs have different epitope
specificities than conventional antibodies given that the paratope of a conventional antibody
is constituted by parts of the heavy and light antibody chain which significantly differs from a
Nb paratope on a single domain (VHH). Here, we have illustrated that competition can occur
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between Nbs and conventional antibodies for epitope binding which enables the selection of di-
agnostic Nb—antigen pairs for antibody detection. Given the possibility of constructing anti-
proteome and anti-infectome libraries [38–41] and the ease of selecting monoclonal Nbs by
phage display, this paves the way to identifying diagnostic Nbs for a range of antibody detec-
tion tests. This approach represents a new biological screening method to identify specific epi-
topes for the development of serological tests with increased specificity. In the case of detecting
tsetse exposure, additional Nb candidates could be selected targeting other salivary biomarkers
from the anti-tsetse sialome Nb library to allow multi-target immunoprofiling of hosts.
Collectively, the prominent induction of anti-Tsal antibodies upon tsetse fly exposure has
been exploited to develop a novel competitive test using Nb technology which remains to be
further evaluated under field conditions. Based on testing of an available set of murine and por-
cine plasmas, the test characteristics of this immunoassay exceeded those of existing assays and
displayed a broad tsetse species range. In addition, the particular assay format implies that no
host-specific detection is required, with the possibility of streamlining anti-Tsal antibody de-
tection in a range of hosts living in the tsetse fly belt to provide a measure for tsetse prevalence,
the impact of an intervention strategy or the efficacy of a protecting barrier or to detect re-inva-
sion of previously cleared areas.
Supporting Information
S1 Fig. Nanobody labeling and primary competitive ELISA tests. (A) Size exclusion chroma-
tography to exclude unlabeled Nbs from the TsalNb-5 (solid line) and TsalNb-11 (dashed line)
HRP-conjugation reactions. (B) Titration of TsalNb-5-HRP and TsalNb-11-HRP and binding
(endpoint O.D.405nm) onto G.m.morsitans saliva coated and blanc coated wells. TsalNb-HRP
working dilutions for subsequent tests were chosen at the start of the declining phase of the
Nb-HRP binding curve (arrows). (C) Inhibition of TsalNb-HRP binding following incubation
of the G.m.morsitans saliva coated wells with several dilutions of tsetse-exposed immune or
naive rabbit serum.
(TIF)
S2 Fig. Primary competitive ELISA tests with porcine plasma samples. Porcine plasmas of
control animals and animals exposed to a low or high tsetse challenge regimen sampled at the
peak of anti-Tsal antibody responses were serially diluted and tested in the competitive ELISA.
Presented data are the percentage inhibition with the means and 95% CI. Significance levels
based on two-way analysis of variance are indicated in the graphs (p<0.05).
(TIF)
S3 Fig. Repeatability and specificity/sensitivity analysis of the competitive immunoassay in
pigs. (A) Scatter plot analysis of the anti-Tsal antibody responses (O.D.405nm) detected in undi-
luted porcine plasma samples (n = 90) with the competitive immunoassay using TsalNb-5-
HRP and TsalNb-11-HRP for detection. Overall test results with the two Nb-HRP detection
moieties were compared using the non-parametric Spearman correlation test with the correla-
tion coefficient r as output. (B) Sensitivity and specificity of the competitive assays were as-
sessed by receiver operating characteristic (ROC) curve analysis of the O.D.405nm values of
exposed (n = 90) and non-exposed mice (n = 21). The area under the ROC curves (AUC) for
detection with TsalNb-5-HRP (solid line) and TsalNb-11-HRP (dotted line) are shown as a
measure for the individual test performances.
(TIF)
A Competitive Tsetse Exposure Test
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003456 February 6, 2015 15 / 18
Acknowledgments
We wish to acknowledge Dr. Hassanzadeh Ghassabeh Gholamreza and Jan Van Gompel (NSF
—VIB) for organizing the alpaca immunization and help with the training of Shahid Hussain.
We also acknowledge Adero Abwao who was involved as master student in part of this project.
We are grateful to Emanuele Pesavento for sharing his experience with the HRP-labeling of
Nbs. This work was supported by the kind technical assistance of Jos Van Hees and Lea Brys.
Author Contributions
Conceived and designed the experiments: GC JVDA. Performed the experiments: GC SH LV.
Analyzed the data: GC. Contributed reagents/materials/analysis tools: GC JVDA. Wrote the
paper: GC JVDA.
References
1. Rayaisse JB, Esterhuizen J, Tirados I, Kaba D, Salou E, et al. (2011) Towards an optimal design of tar-
get for tsetse control: comparisons of novel targets for the control of Palpalis group tsetse in West Af-
rica. PLoS Negl Trop Dis 5: e1332. doi: 10.1371/journal.pntd.0001332 PMID: 21949896
2. Sow A, Sidibe I, Bengaly Z, Bance AZ, Sawadogo GJ, et al. (2012) Irradiated male tsetse from a 40-
year-old colony are still competitive in a Riparian forest in Burkina Faso. PLoS One 7: e37124. doi: 10.
1371/journal.pone.0037124 PMID: 22590652
3. Vreysen MJ, Saleh KM, Ali MY, Abdulla AM, Zhu ZR, et al. (2000)Glossina austeni (Diptera: Glossini-
dae) eradicated on the island of Unguja, Zanzibar, using the sterile insect technique. J Econ Entomol
93: 123–135. PMID: 14658522
4. Aksoy S (2011) Sleeping sickness elimination in sight: time to celebrate and reflect, but not relax. PLoS
Negl Trop Dis 5: e1008. doi: 10.1371/journal.pntd.0001008 PMID: 21364971
5. Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: where do we
stand and what comes next? PLoSMed 5: e55. doi: 10.1371/journal.pmed.0050055 PMID: 18303943
6. Fontaine A, Diouf I, Bakkali N, Misse D, Pages F, et al. (2011) Implication of haematophagous arthro-
pod salivary proteins in host-vector interactions. Parasit Vectors 4: 187. doi: 10.1186/1756-3305-4-187
PMID: 21951834
7. Caljon G, Van Den Abbeele J, Sternberg JM, Coosemans M, De Baetselier P, et al. (2006) Tsetse fly
saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for
exposure assessment. Int J Parasitol 36: 1025–1035. PMID: 16777113
8. Dama E, Cornelie S, Bienvenu Somda M, Camara M, Kambire R, et al. (2013) Identification ofGlossina
palpalis gambiensis specific salivary antigens: towards the development of a serologic biomarker of
human exposure to tsetse flies in West Africa. Microbes Infect 15: 416–427. doi: 10.1016/j.micinf.2013.
03.001 PMID: 23500186
9. Ellis JA, Shapiro SZ, ole Moi-Yoi O, Moloo SK (1986) Lesions and saliva-specific antibody responses in
rabbits with immediate and delayed hypersensitivity reactions to the bites ofGlossina morsitans centra-
lis. Vet Pathol 23: 661–667. PMID: 3811131
10. Poinsignon A, Cornelie S, Remoue F, Grebaut P, Courtin D, et al. (2007) Human/vector relationships
during human African trypanosomiasis: initial screening of immunogenic salivary proteins ofGlossina
species. Am J Trop Med Hyg 76: 327–333. PMID: 17297044
11. Poinsignon A, Remoue F, Rossignol M, Cornelie S, Courtin D, et al. (2008) Human IgG antibody re-
sponse toGlossina saliva: an epidemiologic marker of exposure toGlossina bites. Am J Trop Med Hyg
78: 750–753. PMID: 18458309
12. Somda MB, Bengaly Z, Dama E, Poinsignon A, Dayo GK, et al. (2013) First insights into the cattle sero-
logical response to tsetse salivary antigens: A promising direct biomarker of exposure to tsetse bites.
Vet Parasitol 197: 332–340. doi: 10.1016/j.vetpar.2013.05.018 PMID: 23800781
13. Alves-Silva J, Ribeiro JM, Van Den Abbeele J, Attardo G, Hao Z, et al. (2010) An insight into the sia-
lome ofGlossina morsitans morsitans. BMCGenomics 11: 213. doi: 10.1186/1471-2164-11-213
PMID: 20353571
14. Caljon G, De Ridder K, De Baetselier P, Coosemans M, Van Den Abbeele J (2010) Identification of a
tsetse fly salivary protein with dual inhibitory action on human platelet aggregation. PLoS One 5:
e9671. doi: 10.1371/journal.pone.0009671 PMID: 20351782
A Competitive Tsetse Exposure Test
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003456 February 6, 2015 16 / 18
15. Cappello M, Bergum PW, Vlasuk GP, Furmidge BA, Pritchard DI, et al. (1996) Isolation and characteri-
zation of the tsetse thrombin inhibitor: a potent antithrombotic peptide from the saliva ofGlossina morsi-
tans morsitans. Am J Trop Med Hyg 54: 475–480. PMID: 8644901
16. Van Den Abbeele J, Caljon G, Dierick JF, Moens L, De Ridder K, et al. (2007) TheGlossina morsitans
tsetse fly saliva: general characteristics and identification of novel salivary proteins. Insect Biochem
Mol Biol 37: 1075–1085. PMID: 17785195
17. Dama E, Cornelie S, Camara M, Somda MB, Poinsignon A, et al. (2013) Identification of a Candidate
Synthetic Peptide (Tsgf1) to Monitor Human Exposure to Tsetse Flies in West Africa. PLoS Negl Trop
Dis 7: e2455. doi: 10.1371/journal.pntd.0002455 PMID: 24086785
18. Caljon G, Duguma R, De Deken R, Schauvliege S, Gasthuys F, et al. (2014) Serological responses
and biomarker evaluation in mice and pigs exposed to tsetse fly bites. PLoS Negl Trop Dis 8: e2911.
doi: 10.1371/journal.pntd.0002911 PMID: 24853371
19. International Glossina Genome I (2014) Genome sequence of the tsetse fly (Glossina morsitans): vec-
tor of African trypanosomiasis. Science 344: 380–386. doi: 10.1126/science.1249656 PMID:
24763584
20. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, et al. (1993) Naturally
occurring antibodies devoid of light chains. Nature 363: 446–448. PMID: 8502296
21. Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S (2013) Nanobodies
and their potential applications. Nanomedicine (Lond) 8: 1013–1026. doi: 10.2217/nnm.13.86 PMID:
23730699
22. Caljon G, De Ridder K, Stijlemans B, Coosemans M, Magez S, et al. (2012) Tsetse salivary gland pro-
teins 1 and 2 are high affinity nucleic acid binding proteins with residual nuclease activity. PLoS One 7:
e47233. doi: 10.1371/journal.pone.0047233 PMID: 23110062
23. Frey A, Di Canzio J, Zurakowski D (1998) A statistically defined endpoint titer determination method for
immunoassays. J Immunol Methods 221: 35–41. PMID: 9894896
24. Gidwani K, Picado A, Rijal S, Singh SP, Roy L, et al. (2011) Serological markers of sand fly exposure to
evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial.
PLoS Negl Trop Dis 5: e1296. doi: 10.1371/journal.pntd.0001296 PMID: 21931871
25. Rohousova I, Ozensoy S, Ozbel Y, Volf P (2005) Detection of species-specific antibody response of hu-
mans and mice bitten by sand flies. Parasitology 130: 493–499. PMID: 15991492
26. Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, et al. (2007) Human anti-saliva immune re-
sponse following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis.
Eur J Immunol 37: 3111–3121. PMID: 17935072
27. Schwarz A, Sternberg JM, Johnston V, Medrano-Mercado N, Anderson JM, et al. (2009) Antibody re-
sponses of domestic animals to salivary antigens of Triatoma infestans as biomarkers for low-level in-
festation of triatomines. Int J Parasitol 39: 1021–1029. doi: 10.1016/j.ijpara.2009.01.010 PMID:
19248784
28. Volf P, Grubhoffer L, Hosek P (1993) Characterisation of salivary gland antigens of Triatoma infestans
and antigen-specific serum antibody response in mice exposed to bites of T. infestans. Vet Parasitol
47: 327–337. PMID: 8333137
29. Doucoure S, Mouchet F, Cornelie S, DeHecq JS, Rutee AH, et al. (2012) Evaluation of the human IgG
antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.
PLoS Negl Trop Dis 6: e1487. doi: 10.1371/journal.pntd.0001487 PMID: 22363823
30. Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, et al. (2010) Human antibody responses to
the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vec-
tor control. PLoS One 5: e15596. doi: 10.1371/journal.pone.0015596 PMID: 21179476
31. Orlandi-Pradines E, Almeras L, Denis de Senneville L, Barbe S, Remoue F, et al. (2007) Antibody re-
sponse against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa.
Microbes Infect 9: 1454–1462. PMID: 17913537
32. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, et al. (2009) Human IgG response to a salivary
peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anophe-
les bites. Malar J 8: 198. doi: 10.1186/1475-2875-8-198 PMID: 19674487
33. Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, et al. (2013) gSG6-P1 salivary biomarker dis-
criminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and season-
al malaria areas. Parasit Vectors 6: 68. doi: 10.1186/1756-3305-6-68 PMID: 23497646
34. Schwarz A, Juarez JA, Richards J, Rath B, Machaca VQ, et al. (2011) Anti-triatomine saliva immunoas-
says for the evaluation of impregnated netting trials against Chagas disease transmission. Int J Parasi-
tol 41: 591–594. doi: 10.1016/j.ijpara.2011.02.001 PMID: 21426907
A Competitive Tsetse Exposure Test
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003456 February 6, 2015 17 / 18
35. Deckers N, Saerens D, Kanobana K, Conrath K, Victor B, et al. (2009) Nanobodies, a promising tool for
species-specific diagnosis of Taenia solium cysticercosis. Int J Parasitol 39: 625–633. doi: 10.1016/j.
ijpara.2008.10.012 PMID: 19041315
36. Huang L, Reekmans G, Saerens D, Friedt JM, Frederix F, et al. (2005) Prostate-specific antigen immu-
nosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced
sandwich assays. Biosens Bioelectron 21: 483–490. PMID: 16076438
37. He T, Wang Y, Li P, Zhang Q, Lei J, et al. (2014) Nanobody-based enzyme immunoassay for aflatoxin
in agro-products with high tolerance to cosolvent methanol. Anal Chem 86: 8873–8880. doi: 10.1021/
ac502390c PMID: 25079057
38. Yardehnavi N, Behdani M, Pooshang Bagheri K, Mahmoodzadeh A, Khanahmad H, et al. (2014) A
camelid antibody candidate for development of a therapeutic agent againstHemiscorpius lepturus en-
venomation. FASEB J.
39. Richard G, Meyers AJ, McLean MD, Arbabi-Ghahroudi M, MacKenzie R, et al. (2013) In vivo neutraliza-
tion of alpha-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc anti-
body. PLoS One 8: e69495. doi: 10.1371/journal.pone.0069495 PMID: 23894495
40. Hassanzadeh-Ghassabeh G, Saerens D, Muyldermans S (2011) Generation of anti-infectome/anti-
proteomenanobodies. Methods Mol Biol 790: 239–259. doi: 10.1007/978-1-61779-319-6_19 PMID:
21948420
41. Saerens D, Stijlemans B, Baral TN, Nguyen Thi GT, Wernery U, et al. (2008) Parallel selection of multi-
ple anti-infectome Nanobodies without access to purified antigens. J Immunol Methods 329: 138–150.
PMID: 17996887
A Competitive Tsetse Exposure Test
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003456 February 6, 2015 18 / 18
